Filing Details
- Accession Number:
- 0001140361-15-010627
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-06 10:15:47
- Reporting Period:
- 2015-03-04
- Filing Date:
- 2015-03-06
- Accepted Time:
- 2015-03-06 10:15:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1134545 | D Johnny Powers | One Idexx Drive Westbrook ME 04092 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-03-04 | 2,372 | $34.37 | 13,267 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-03-04 | 2,000 | $53.31 | 15,267 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-03-04 | 6,168 | $158.49 | 9,099 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2015-03-04 | 2,372 | $0.00 | 2,372 | $34.37 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2015-03-04 | 2,000 | $0.00 | 2,000 | $53.31 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-02-13 | No | 4 | M | Direct | |
| 14,168 | 2017-02-13 | No | 4 | M | Direct |
Footnotes
- The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $158.4650 to $158.5750, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 2,373 shares on 02/14/2010, 02/14/2011, 02/14/2012 and 02/14/2013, and the remaining 2,372 shares on 02/14/2014.
- Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 3,609 shares on 02/14/2011, 02/14/2012 and 02/14/2013, 3,608 shares on 02/14/2014, and the remaining 1,733 shares on 02/14/2015.
Billionaire Hedge Funds
